Somatostatin Receptor Imaging in Cardiac Sarcoidosis

Rigshospitalet, Denmark

Overview

The purpose of the trial is to determine the accuracy of Cu-64 labelled DOTATATE for diagnosing cardiac sarcoidosis using PET/CT or PET/MRI.

Study Type

OBSERVATIONAL

Conditions

Cardiac Sarcoidosis

Interventions

Cu-64 DOTATATEDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: Group A: Suspected cardiac sarcoidosis Group B: Known cardiac sarcoidosis, clinical follow-up Group C: Myocarditis or dilated cardiomyopathy (Non-cardiac sarcoidosis) Exclusion Criteria: Infection Pregnancy Severe claustrophobia Weight \>140 kg

Locations (1)

Rigshospitalet

Copenhagen, Denmark

Outcomes

Primary Outcomes

Sensitivity to detect cardiac sarcoidosis

Time frame: 1 day at PET/CT examination

Specificity to detect cardiac sarcoidosis

Time frame: 1 day at PET/CT examination

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.